Safety and Efficacy of Pregabalin in Patients With Diabetic Peripheral Neuropathy.
This study has been completed.
Information provided by:
First received: August 30, 2005
Last updated: August 15, 2007
Last verified: August 2007
To evaluate long-term efficacy and safety of pregabalin in patients with diabetic peripheral neuropathy.
|Study Design:||Allocation: Non-Randomized
Endpoint Classification: Safety/Efficacy Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment
|Official Title:||An Open-Label, Extension Safety and Efficacy Study of Pregabalin in Patients With Painful Diabetic Peripheral Neuropathy.|
Resource links provided by NLM:
Genetics Home Reference related topics: Charcot-Marie-Tooth disease hereditary neuropathy with liability to pressure palsies
Genetic and Rare Diseases Information Center resources: Charcot-Marie-Tooth Disease Hereditary Neuropathy With Liability to Pressure Palsy Roussy Levy Syndrome Neurotoxicity SyndromesU.S. FDA Resources
Further study details as provided by Pfizer:
Contacts and Locations